Mammographic breast density as an intermediate phenotype for breast cancer

被引:482
作者
Boyd, NF
Rommens, JM
Vogt, K
Lee, V
Hopper, JL
Yaffe, MJ
Paterson, AD
机构
[1] Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2M9, Canada
[2] Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada
[3] Univ Melbourne, Ctr Genet Epidemiol, Melbourne, Vic, Australia
[4] Sunnybrook & Womens Hlth Sci Ctr, Toronto, ON, Canada
[5] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada
基金
英国医学研究理事会;
关键词
D O I
10.1016/S1470-2045(05)70390-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The amount of radiologically dense breast tissue appearing on a mammogram varies between women because of differences in the composition of breast tissue, and is referred to here as mammographic density. This review presents evidence that mammographic density is a strong risk factor for breast cancer, and that risk of breast cancer is four to five times greater in women with density in more than 75% of the breast than in women with little or no density in the breast. Density in more than 50% of the breast could account for about a third of breast cancers. The epidemiology of mammographic density is consistent with its being a marker of susceptibility to breast cancer. Twin studies have shown that the proportion of the breast occupied by density, at a given age, is highly heritable, and inherited factors explain 63% of the variance. Mammographic breast density has the characteristics of a quantitative trait and might be determined by genes that are easier to identify than those for breast cancer itself The genes that determine breast density might also be associated with risk of breast cancer, and their identification is also likely to provide insights into the biology of the breast and identify potential targets for preventive strategies.
引用
收藏
页码:798 / 808
页数:11
相关论文
共 86 条
[1]   Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].
Antoniou, A ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Loman, N ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130
[2]  
BARTOW SA, 1997, RAD PATTERNS MORPH, V13, P263
[3]  
Bérubé S, 2004, CANCER EPIDEM BIOMAR, V13, P1466
[4]  
Boyd N, 2002, CANCER EPIDEM BIOMAR, V11, P1048
[5]  
Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133
[6]   Heritability of mammographic density, a risk factor for breast cancer [J].
Boyd, NF ;
Dite, GS ;
Stone, J ;
Gunasekara, A ;
English, DR ;
McCredie, MRE ;
Giles, GG ;
Tritchler, D ;
Chiarelli, A ;
Yaffe, MJ ;
Hopper, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (12) :886-894
[7]   Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: Results from a randomized trial [J].
Boyd, NF ;
Greenberg, C ;
Lockwood, G ;
Little, L ;
Martin, L ;
Byng, J ;
Yaffe, M ;
Tritchler, D .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (07) :488-496
[8]   The association of breast mitogens with mammographic densities [J].
Boyd, NF ;
Stone, J ;
Martin, LJ ;
Jong, R ;
Fishel, E ;
Yaffe, M ;
Hammond, G ;
Minkin, S .
BRITISH JOURNAL OF CANCER, 2002, 87 (08) :876-882
[9]   RELATIONSHIP BETWEEN MAMMOGRAPHIC AND HISTOLOGICAL RISK-FACTORS FOR BREAST-CANCER [J].
BOYD, NF ;
JENSEN, HM ;
COOKE, G ;
HAN, HL .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (15) :1170-1179
[10]   QUANTITATIVE CLASSIFICATION OF MAMMOGRAPHIC DENSITIES AND BREAST-CANCER RISK - RESULTS FROM THE CANADIAN NATIONAL BREAST SCREENING STUDY [J].
BOYD, NF ;
BYNG, JW ;
JONG, RA ;
FISHELL, EK ;
LITTLE, LE ;
MILLER, AB ;
LOCKWOOD, GA ;
TRITCHLER, DL ;
YAFFE, MJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (09) :670-675